- Home
- LPTX vs RMTI Comparison
LPTX vs RMTI Comparison
Compare LPTX & RMTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LPTX
- RMTI
- Stock Information
- Founded
- LPTX 2011
- RMTI 1994
- Country
- LPTX United States
- RMTI United States
- Employees
- LPTX N/A
- RMTI N/A
- Industry
- LPTX Biotechnology: Biological Products (No Diagnostic Substances)
- RMTI Biotechnology: Pharmaceutical Preparations
- Sector
- LPTX Health Care
- RMTI Health Care
- Exchange
- LPTX Nasdaq
- RMTI Nasdaq
- Market Cap
- LPTX 35.4M
- RMTI 41.0M
- IPO Year
- LPTX N/A
- RMTI 1998
- Fundamental
- Price
- LPTX $0.48
- RMTI $1.09
- Analyst Decision
- LPTX Hold
- RMTI Strong Buy
- Analyst Count
- LPTX 1
- RMTI 2
- Target Price
- LPTX N/A
- RMTI $4.00
- AVG Volume (30 Days)
- LPTX 7.7M
- RMTI 540.6K
- Earning Date
- LPTX 11-13-2025
- RMTI 11-12-2025
- Dividend Yield
- LPTX N/A
- RMTI N/A
- EPS Growth
- LPTX N/A
- RMTI N/A
- EPS
- LPTX N/A
- RMTI N/A
- Revenue
- LPTX N/A
- RMTI $87,966,000.00
- Revenue This Year
- LPTX N/A
- RMTI N/A
- Revenue Next Year
- LPTX N/A
- RMTI $10.99
- P/E Ratio
- LPTX N/A
- RMTI N/A
- Revenue Growth
- LPTX N/A
- RMTI N/A
- 52 Week Low
- LPTX $0.22
- RMTI $0.78
- 52 Week High
- LPTX $4.79
- RMTI $5.15
- Technical
- Relative Strength Index (RSI)
- LPTX 47.84
- RMTI 37.95
- Support Level
- LPTX $0.43
- RMTI $1.12
- Resistance Level
- LPTX $0.56
- RMTI $1.19
- Average True Range (ATR)
- LPTX 0.06
- RMTI 0.06
- MACD
- LPTX -0.02
- RMTI -0.00
- Stochastic Oscillator
- LPTX 16.04
- RMTI 5.26
About LPTX Leap Therapeutics Inc.
Leap Therapeutics Inc is a biopharmaceutical company developing novel biomarker-targeted antibody therapies designed to treat patients with cancer by inhibiting fundamental tumor-promoting pathways, targeting cancer-specific cell surface molecules, and harnessing the immune system to attack cancer cells. The company's key clinical-stage drug candidate is sirexatamab (DKN-01), which targets Dickkopf-related protein 1 (DKK1) and is being studied in a clinical trial in patients with colorectal cancer. In addition, it also has a preclinical program to develop a proprietary monoclonal antibody, called FL-501 which works by inhibiting the GDF-15 protein.
About RMTI Rockwell Medical Inc.
Rockwell Medical Inc is a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products for dialysis providers. It is a supplier of liquid bicarbonate concentrates, and acid and dry bicarbonate concentrates for dialysis patients in the United States. The company's products include CitraPure citric acid concentrate, RenalPure liquid acid concentrate, and SteriLyte bicarbonate concentrate among others.